A Member of Forkhead Transcription Factor FKHRL1 Is a Downstream Effector of STI571-induced Cell Cycle Arrest in BCR-ABL-expressing Cells-Reference-Cited by-同舟云学术

A Member of Forkhead Transcription Factor FKHRL1 Is a Downstream Effector of STI571-induced Cell Cycle Arrest in BCR-ABL-expressing Cells

Published:2003-02 Issue:8 Volume:278 Page:6411-6419
ISSN:0021-9258
Container-title:Journal of Biological Chemistry
language:en
Short-container-title:Journal of Biological Chemistry

Author:

Komatsu Norio,Watanabe Tomoko,Uchida Mie,Mori Masaki,Kirito Keita,Kikuchi Satoru,Liu Qifa,Tauchi Tetsuzo,Miyazawa Keisuke,Endo Hitoshi,Nagai Tadashi,Ozawa Keiya

Publisher

Elsevier BV

Subject

Cell Biology,Molecular Biology,Biochemistry

Reference49 articles.

1. In vitro transformation of immature hematopoietic cells by the P210 BCR/ABL oncogene product of the Philadelphia chromosome.

2. Tyrosine Kinase Activity and Transformation Potency of bcr-abl Oncogene Products

3. Transformation of an interleukin 3-dependent hematopoietic cell line by the chronic myelogenous leukemia-specific P210bcr/abl protein.

4. BCR-ABL-mediated inhibition of apoptosis with delay of G2/M transition after DNA damage: a mechanism of resistance to multiple anticancer agents

Cited by 101 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Expression of genes potentially involved in loss of response in patients with chronic myeloid leukemia;Gene;2024-02

2. Elevated CDKN1A (P21) mediates β-thalassemia erythroid apoptosis, but its loss does not improve β-thalassemic erythropoiesis;Blood Advances;2023-11-16

3. Elevated p21 (CDKN1a) mediates β-thalassemia erythroid apoptosis but its loss does not improve β-thalassemic erythropoiesis;2022-03-04

4. SIRT1 regulates the phosphorylation and degradation of P27 by deacetylating CDK2 to promote T-cell acute lymphoblastic leukemia progression;Journal of Experimental & Clinical Cancer Research;2021-08-18

5. LncRNA Blnc1 mediates the permeability and inflammatory response of cerebral hemorrhage by regulating the PPAR-γ/SIRT6/FoxO3 pathway;Life Sciences;2021-02